Royce & Associates LP raised its holdings in shares of RadNet Inc. (NASDAQ:RDNT) by 33.8% in the 1st quarter, Holdings Channel reports. The firm owned 364,423 shares of the medical research company’s stock after buying an additional 92,000 shares during the period. Royce & Associates LP’s holdings in RadNet were worth $4,515,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also made changes to their positions in RDNT. US Bancorp DE acquired a new stake in RadNet during the 1st quarter valued at $31,000. Quantamental Technologies LLC acquired a new stake in shares of RadNet during the first quarter worth $34,000. Financial Gravity Wealth Inc. acquired a new stake in shares of RadNet during the first quarter worth $35,000. PNC Financial Services Group Inc. acquired a new stake in shares of RadNet during the fourth quarter worth $36,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of RadNet by 157.8% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,624 shares of the medical research company’s stock worth $37,000 after buying an additional 2,218 shares in the last quarter. 64.10% of the stock is owned by institutional investors and hedge funds.

RDNT has been the subject of a number of research reports. BidaskClub downgraded RadNet from a “buy” rating to a “hold” rating in a report on Friday, March 1st. Zacks Investment Research raised RadNet from a “sell” rating to a “hold” rating in a report on Tuesday, March 5th. Raymond James downgraded RadNet from a “strong-buy” rating to an “outperform” rating and lifted their target price for the stock from $16.00 to $17.50 in a report on Friday, March 15th. They noted that the move was a valuation call. ValuEngine downgraded RadNet from a “buy” rating to a “hold” rating in a report on Tuesday, March 19th. Finally, TheStreet raised RadNet from a “c” rating to a “b-” rating in a report on Friday, March 15th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the company. RadNet currently has a consensus rating of “Hold” and an average target price of $17.75.

RDNT opened at $12.22 on Tuesday. RadNet Inc. has a fifty-two week low of $9.97 and a fifty-two week high of $16.54. The company has a debt-to-equity ratio of 4.74, a current ratio of 0.72 and a quick ratio of 0.72. The firm has a market cap of $604.98 million, a PE ratio of 18.52, a PEG ratio of 4.60 and a beta of 1.04.

RadNet (NASDAQ:RDNT) last posted its quarterly earnings results on Thursday, May 9th. The medical research company reported ($0.08) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.08). The business had revenue of $271.50 million during the quarter, compared to the consensus estimate of $256.30 million. RadNet had a return on equity of 22.38% and a net margin of 3.53%. RadNet’s revenue for the quarter was up 17.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.15) earnings per share. On average, sell-side analysts predict that RadNet Inc. will post 0.35 EPS for the current year.

In related news, insider John V. Crues sold 20,000 shares of the business’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $13.15, for a total value of $263,000.00. Following the completion of the transaction, the insider now owns 524,097 shares of the company’s stock, valued at $6,891,875.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Mark Stolper sold 15,000 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $14.99, for a total value of $224,850.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 66,556 shares of company stock valued at $935,754. 7.56% of the stock is owned by insiders.

TRADEMARK VIOLATION WARNING: This report was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.watchlistnews.com/royce-associates-lp-increases-holdings-in-radnet-inc-rdnt/3031194.html.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.

Featured Story: What impact do institutional investors have on markets?

Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet Inc. (NASDAQ:RDNT).

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.